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Abstract 
There is very little known about exercise rehabilitation approaches for older adults with multiple sclerosis (MS), 
yet this growing segment of the MS population experiences declines in cognition and mobility associated 
with disease progression and aging. We conducted a RCT examining the feasibility of a 12-week, home-based 
Square-Stepping Exercise (SSE) program in older adults with MS. Older adults with MS (N = 26) with mild-to-
moderate levels of disability were recruited and randomized into the intervention (i.e., SSE) or a minimal 
activity, attention-control conditions. Participants in the SSE condition received a mat for home-based practice 
of the step patterns, an instruction manual, and a logbook along with a pedometer for monitoring compliance. 
Both conditions received weekly Skype™ calls and had biweekly meetings with an exercise trainer. Feasibility 
was assessed based on process, resource, management and scientific outcomes. Regarding scientific outcomes, 
participants in both conditions completed in-lab assessments before and after the 12-week period. Twenty-five 
participants completed the study (96%) and the total cost of the study was $13,387.00 USD. Pedometer data 
demonstrated good compliance with the SSE intervention condition. Effect sizes calculated for all treatment 
outcomes ranged from small-to-moderate for both mobility and cognitive variables between the intervention 
and attention-control conditions, thereby providing preliminary evidence that participation in the SSE program 
may improve cognition and mobility function. The results support the feasibility, acceptability, and possible 
efficacy of a home-based SSE intervention for older adults with MS. 
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1. Introduction 
There are increasing numbers of adults with multiple sclerosis (MS) who are now aging into older adulthood. 
This is reflected by the shifting age demography of persons with MS whereby there is an expanding prevalence 
of older adults living with MS [1]. Aging with MS as a disabling disease presents a number of consequences, and 
older adults with MS present with poor health status and functioning, cognitive and ambulatory difficulty, and 
dependence for activities of daily living [[2], [3], [4], [5], [6], [7]]. There is further evidence of a faster rate of 
disability progression among older adults with MS [8], yet there are no approved disease-modifying 
therapies (DMTs) for adults with MS beyond 65 years of age. This is mostly due to the paucity of research 
studies including this age group in trials. Nevertheless, some evidence indicates that DMTs have no or very 
modest effect for slowing disability in this demographic of persons with MS [9]. 
Researchers and clinicians have become interested in exercise training as an approach for managing the 
consequences of aging and MS. This is largely based on evidence for benefits of exercise in MS [10] and older 
adults in the general population [11] separately, but there have been a few interventions focusing on the 
beneficial effects of exercise for older adults with MS [12]. We further note that the rates of participation in 
physical activity and exercise are exceedingly low in older adults with this MS [13,14] and that this population 
does not meet current recommendations of physical activity necessary for accruing health benefits. Several 
factors may interfere with physical activity and exercise participation in older adults with MS, including 
increasing age, perception that exercise is too difficult, cost of exercise programs and lack of low-cost and 
accessible recreational facilities [15]. Such observations must be accounted for in the design of exercise training 
programs for older adults that are consistent with recommendations regarding exercise for persons with MS 
[16]. 
We recently described and proposed a methodological protocol paper involving a feasibility study of the square-
stepping exercise (SSE) in older adults with MS [17]. The SSE program was originally developed by Japanese 
researchers and focused on improving functional fitness (e.g., lower limb muscle strength, walking ability, 
balance, reduce the risk of falls) and enhancing cognition in older adults of the general population [18]. To this 
end, we opted for the SSE intervention for its potential benefit to improve clinical aspects in older adults with 
MS. The SSE-MS project is a 12-week, home-based, exercise training program developed to be an easy-to-do and 
fun exercise with the potential to improve mobility and cognition in individuals with MS in the older adulthood. 
The present manuscript reports results (i.e., outcomes) regarding the process, resource, management, and 
scientific feasibility metrics on the feasibility of SSE-MS Project in adults with MS aged 60 years and older. The 
results were reported in accordance with current recommendations and guidelines for feasibility trials [19]. 
2. Methods 
2.1. Ethical approval 
This feasibility study was a randomized controlled trial (RCT) conducted between October 2016 and September 
2017. The study protocol was approved by a university institutional review board (IRB) and all participants 
signed an informed consent document before data collection. 
2.2. Participant recruitment and eligibility 
Participants were recruited from the Midwest region of United States using (i) the North American Research 
Committee on Multiple Sclerosis (NARCOMS), (ii) a database of people with MS who had previously participated 
in studies conducted by researchers in the Exercise Neuroscience Research Laboratory, (iii) interactions with 
potential participants during MS events and MS-specific support groups, (iv) advertisement on the research 
laboratory's website, and (v) advertisement in local newspapers. Participant recruitment was an ongoing process 
over the course of the study. 
Recruitment flyers and newspaper advertisements provided detailed eligibility criteria, and included contact 
information (i.e., telephone and email) for the researchers. Inclusion criteria for the study included: (a) 60 years 
and older; (b) clinically definitive diagnosis of MS; (c) relapse-free for the past 30 days; (d) ability to walk with or 
without an assistive device (e.g., cane); (e) willing and able to participate in the 12-week home-based 
intervention; (f) non-exerciser (operationalized as not engaging in structured exercise 2 + days/week); (g) 
asymptomatic (i.e., one or fewer affirmatives on the Physical Activity Readiness Questionnaire (PAR-Q)) or 
physician approval for undertaking exercise training for those with 2 or more affirmatives on the PAR-Q [20], (h) 
signed medical release form; and (i) scoring ≥13 points in the Telephone Interview for Cognitive Status, 
indicating no more than mild cognitive impairment [21]. Participants who did not meet those criteria were 
excluded from study participation. We sought a sample size exceeding 12 participants per group, as it is believed 
to be acceptable for pilot and feasibility studies involving RCT study designs [22]. We did not conduct a formal 
sample size calculation, as this was a feasibility study. 
2.3. Procedure 
Participants who successfully enrolled in the study were scheduled for a visit to the Exercise Neuroscience 
Research Laboratory. This visit started with a review and provision of a written informed consent document. 
Participants then undertook baseline assessments (e.g., functional mobility, walking speed and endurance, 
cognitive assessments) and were randomized using concealed allocation into the intervention condition or the 
attention control condition. This involved (a) a research staff member not involved in the study pre-preparing 
opaque sealed envelopes with slips of paper containing group allocation and storing these in a randomization 
container and (b) another research staff member involved in the study choosing an envelope. This determined 
group allocation. Because of the feasibility pilot nature of the study, outcome assessors were not blind to group 
allocation. The intervention was delivered over a 12-week period and we further collected outcome assessments 
both during (e.g., communication and safety) and after (e.g., treatment effect). All participants received $250 as 
incentive for participation. Participation included two in-laboratory assessment (i.e., pre- and post-intervention), 
six site visits/encounters with the exercise trainer, weekly skype calls, and the home practice. 
2.3.1. Intervention condition 
Table 1 and Fig. 1 display intervention progression and step pattern levels examples. SSE was performed on a 
thin mat of 250 × 100 cm, partitioned into 40 smaller squares (25 cm per side). The program provides sequences 
of stepping patterns wherein participants learn and practice specific stepping routines by progressively stepping 
along the mat length direction and avoid treading on the lines of the squares. The exercise intervention group 
received in-person supervised instruction at a university laboratory setting followed by ongoing home-based 
practice with weekly Skype™ calls for monitoring and compliance check. Participants further received a 
pedometer (YAMAX SW-200), which was worn during all SSE home-sessions and a logbook to record the date, 
start and end time, and the number of steps per SSE session. Importantly, this study was not designed to 
increase average steps, and participants were not asked to reach or perform a certain number of steps per 
session. The pedometer was used with the purpose only of monitoring compliance with the program (i.e., 
participants increased the number of steps as expected based on doing the prescribed step patterns per 
session). Participants further provided written responses of level of perceived exertion, feeling, enjoyment, and 
physical and mental fatigue per session in the logbook. This information was retrieved during the biweekly 
encounters for monitoring compliance with the program. The exercise intervention started with sessions being 
performed twice a week with a duration between 10 and 15 min and progressed to 5 sessions per week with a 
duration between 25 and 30 min per session. Participants started with basic step patterns that focused on 
walking-like movements and gradually progressed to more complex step patterns requiring forward, lateral, 
diagonal and backwards movements. Over the course of the intervention, participants had a total of six in-
person encounters (one every two weeks) with the exercise trainer to be familiarized with and receive verbal 
and visual instructions about the step patterns. Participants then practiced the sequence of step patterns 
designated for the two-week period at home until the next meeting. For additional details in the intervention 
please see reference elsewhere [17]. 
Table 1. Progression of the arms of the SSE-MS program. 
Week Intervention    Control     
Frequency 
(days/week) 
Duration 
(minutes) 
Number 
of step 
patterns 
Level of 
step 
patterns 
Frequency 
(days/week) 
Duration 
(minutes) 
Stretching 
exercises 
Sets/time 
for each 
exercise 
1⁎ 2 10–15 4 B1; B1; 
B1; B2 
2 10 H & N 1/30 s 
2 2 10–15 +4 B1; B1, 
B2, B2 
2 10 W1 + S 1/30 s 
3⁎ 3 15–20 +4 B2; B2; 
B2; B2; I1 
3 15 W1–
2 + SR 
2/20 s 
4 3 15–20 +4 B2; B2; 
I1; I1; I1 
3 15 W1–3 + E 2/20 s 
5⁎ 3 15–20 +4 I1; I1; I1; 
I1; I2 
3 15 W1–
4 + FE 
2/20 s 
6 4 20–25 +4 I1; I1; I1; 
I2; I2; I2 
4 20 W1–
5 + Ha 
2/20 s 
7⁎ 4 20–25 +4 I2; I2; I2; 
I2; I2; I3 
4 20 W1–
6 + W 
3/20 s 
8 4 20–25 +4 I2; I2; I2; 
I3; I3; I3 
4 20 W1–7 + T 3/20 s 
9⁎ 5 25–30 +4 I3; I3; I3; 
I3; I3; I3; 
A1 
5 25 W1–
8 + Hi 
3/20 s 
10 5 25–30 +4 I3; I3; I3; 
I3; A1; 
A1; A1 
5 25 W1–9 + A 4/20 s 
11⁎ 5 25–30 +4 A1; A1; 
A1; A1; 
A1; A1; 
A2; A2 
5 30 W1–
10 + FoE 
4/20 s 
12 5 25–30 +4 A1; A2; 
A2; A2; 
A2; A2; 
A3; A3 
5 30 W11 4/20 s 
⁎Meeting with SSE/Stretching trainer; B1 = Beginner one; B2 = Beginner two; I1 = Intermediate one; 
I2 = Intermediate two; I3 = Intermediate three; A1 = Advanced one; A2 = Advanced two; A3 = Advanced three; 
H = Head; N = Neck; W1, 11 = Week one to eleven; S = Shoulder; SR = Shoulder Range; E = Elbow; FE = Forearm 
Exercises; Ha = Hand; W = Wrist; T = Trunk; Hi = Hip; A = Ankle; FoE = Foot Exercise. 
 
Fig. 1. Examples of the three different levels of patterns available in the square-stepping exercise program. 
 
2.3.2. Control condition 
The stimulus was a light intensity stretching and minimal muscle strengthening program based on an illustrated 
manual for persons with MS developed by the National Multiple Sclerosis Society that involves major muscle 
groups of the upper and lower body. This stimulus is common in RCTs of exercise training in older adults [4] and 
serves as an attention-control condition to account for social interaction with the exercise trainers. Participants 
received graphical instructions on the designated stretching exercises and the intervention progressed with the 
inclusion of more exercises and sets over the course of the program (i.e., 12-week period). Participants in the 
control group were involved in the same hybrid of biweekly, in-person supervised instruction as the intervention 
group, followed by ongoing home-based practice (i.e., 2–5 days/week) with weekly Skype™ monitoring. 
Compliance for the control group was monitored through the weekly Skype™ calls and through the five scales 
(i.e., level of perceived exertion, feeling, enjoyment, and physical and mental fatigue) that were completed at 
the end of each home-based session. 
2.4. Feasibility metrics 
This study assessed outcomes based on process, resource, management and scientific metrics of feasibility. All 
feasibility metrics components assessed in this study are summarized in Table 2 along with the methods for 
collecting and assessing relevant data. 
Table 2. Feasibility metrics; proposed methodology and importance to future research in MS. 
Metric SSEMS monitored and 
assessed 
Data source Outcome variable 
computational method 
Process; assesses 
participant 
recruitment and 
retention 
a. 
Recruitment and 
refusal rates 
b. 
Retention, attrition 
and adherence rates 
a. 
Central database 
recording number of 
participants recruited via 
each recruitment method 
(i.e., telephone, email, 
participation in MS-
related events and 
newspaper); number of 
excluded participants and 
reason 
b. 
Central database 
recording adherence to 
study completion (i.e., 
logbook, weekly phone 
calls, and step count 
during SSE home 
sessions), participants 
completing the study (i.e., 
follow up); attrition and 
reason. 
a. 
Recruitment rate was 
calculated dividing total 
number of participants enrolled 
from each method adopted by 
total number of participants 
contacted 
b. 
Retention rate was calculated 
as the number of participants 
who completed follow-up 
assessments from those who 
were randomized. Attrition 
rates was calculated as the 
number of participants who did 
not complete follow-up 
assessments. Adherence was 
calculated as the total number 
of consenting participants who 
received intervention allocation 
Resources; assesses 
communication and 
monetary 
requirements of the 
study 
c. 
Communication with 
participants 
d. 
Communication needs 
of participants and 
staff 
e. 
Monetary costs of 
research 
c. 
Central database 
recording length of initial 
recruitment, weekly 
phone calls and meetings 
with exercise trainer. 
d. 
Central database for 
intervention participants 
recording preferred 
communication method 
(i.e., Skype video calls, 
regular telephone calls) 
and call time 
e. 
Expenditure spread sheet 
recording overall costs of 
c. 
Recruitment time was 
calculated based on the mean 
time pend during phone 
calls/screening time for 
participation, time for medical 
release forms to be signed and 
returned by their physicians 
d. 
Preferred time of 
communication method was 
calculated as the number of 
participants opting for skype 
video calls or regular telephone 
calls 
e. 
intervention (i.e., SSE 
mats, instructional 
materials, pedometers, 
participant compensation) 
The costs of the study were 
calculated as the total 
monetary cost in US dollars of 
producing materials (i.e., 
manual, paper-pencil tests 
materials, log-books); SSE 
materials (i.e., mats, 
pedometers); and participant 
compensation 
Management; 
assesses data 
management and 
safety reporting 
during the study 
f. 
IRB approval 
procedures 
g. 
Staff preparation and 
report time for 
participant 
communication 
h. 
Time and accuracy in 
data collection/entry 
i. 
Reporting and 
handling of adverse 
events (AE), serious 
adverse events (SAE) 
and clinical 
emergencies 
f. 
Record of time (i.e., days) 
to achieve initial IRB 
approval 
g. 
Preparation spread sheet 
recording recruitment 
database preparation time 
(min), material 
preparation time (min) 
recruitment and database 
preparation; staff 
meetings (min) 
h. 
Preparation spread sheet 
recording assessment 
time (min) and time to 
data enter and check 
(min) 
i. 
Preparation spread sheet 
recording adverse events 
(AE), serious adverse 
events (SAE) and clinical 
emergencies as wells 
actions taken 
f. 
IRB approval time was 
calculated as the amount of 
days taken from submission to 
approval notification 
g. 
Staff preparation and reporting 
time were calculated as the 
time with staff meetings, create 
recruitment database, recruit 
participants, conversation with 
participant over the phone (i.e., 
study explanation, answering 
questions), preparation of 
participants' materials; and 
entering and checking study's 
data 
h. 
This was calculated based on 
the time taken for each 
participant assessment and 
information to be entered and 
checked in the database 
i. 
Health problems reported by 
the participants over the course 
of the study period was 
computed. This included: MS 
symptoms exacerbation (e.g., 
increased fatigue, pain), MS 
relapse (e.g., acute worsening 
of neurological symptoms), 
injury (e.g, sprains, fracture), 
and illness (e.g., infections) 
Scientific; assesses 
the safety, burden 
and treatment effect 
of the study 
j. 
AEs, SAEs and clinical 
emergencies 
k. 
Participants 
experience, burden, 
and compliance 
j. 
Database recording 
reported adverse health 
problems, relapses and 
AEs occurring during the 
study period 
k. 
j. 
same as item i 
k. 
This study adopted scales for 
physical and mental fatigue, 
enjoyment, feelings and 
program intensity 
during the 
intervention 
l. 
Treatment effect 
Database recording 
exercise participation and 
burden reported by 
participants during the 
intervention (i.e., scales 
measuring level of mental 
and physical fatigue, level 
of enjoyment, feelings and 
perceived exertion) 
l. 
Mobility outcomes (i.e., 
T25FW, TUG, 6 MW); 
Functional Fitness 
outcome (i.e., SPPB); 
cognitive outcomes (i.e., 
SDMT, CVLT, BVMT) 
l. 
Outcomes were collected using 
valid, reliable and 
recommended test to be 
adopted in exercise trials 
involving persons with MS 
 
2.4.1. Physical and cognitive outcome measures 
We included measures of walking mobility, cognition, and physical function for capturing possible beneficial 
effects of the SSE protocol. The Timed 25-foot Walking (T25FW) [24,25], Six-minute Walk (6 MW) [26,27] and 
Timed Up and Go (TUG) [[28], [29], [30]] represented standard performance measures of walking mobility. The 
Brief International Cognitive Assessment for MS, including the oral version of the Symbol Digit Modalities 
Test (SDMT), Brief Visuospatial Memory Test (BVMT), and the California Verbal Learning Test (CVLT) represented 
the cognitive endpoints [31]. The Short Physical Performance Battery (SPPB) represented a measure of physical 
function for older adults with MS [32]. 
2.5. Data analysis 
Data were analyzed using SPSS version 24.0 (SPSS Inc. Armonk, NY: IBM Corp.). Basic descriptive statistics (mean, 
median, standard deviation (SD), interquartile range) were used to present the data regarding demographic 
(e.g., age) and clinical characteristics (e.g., MS duration, Expanded Disability Status Scale (EDSS)). Process 
feasibility data were described as total number and percentage (i.e., recruitment). Resource feasibility data were 
described as total number and percentage (i.e., retention and communication). The scientific metrics of efficacy 
were examined using mixed-factor ANOVA. Condition was the between-subjects factor and time was within-
subjects factor. Due to the nature of the study (i.e., feasibility), covariates were not included and statistical 
analysis served primarily for the observation of Eta-squared (η2) values rather than statistical significance. Effect 
sizes associated with F-statistics were expressed as ηp2. Effect sizes were based on a difference in mean scores 
over time between groups were expressed as Cohen's d [33]. 
3. Results 
3.1. Participant demographic and clinical characteristics 
Detailed demographics and clinical characteristics of the overall sample and sample by conditions (i.e., 
intervention and attention-control) are presented in Table 3. The average age of participants was 64.3 (SD = 4.5) 
years. The majority of the sample was female (88.5%) and married (77.3%). Further, all participants self-
identified as Caucasian. Thirty-five percent of the sample reported having a master's degree, 58% of the 
participants reported being retired, and 69% reported an annual income of $40,000 or greater. Relapsing-
remitting MS was reported by 88.5% of participants with an average duration of the disease of 21.1 (SD = 10.7) 
years. The sample had a moderate level of disability (EDSS = 4.0, IQR = 2.5). No significant differences were 
observed in any demographic or clinical metrics between conditions. 
Table 3. Baseline demographic and clinical characteristics of the sample.  
Overall 
(n = 25) 
Intervention condition 
(n = 15) 
Control condition 
(n = 10) 
Age, mean (SD) 64.3 (4.5) 63.8 (4.1) 65.1 (5.2) 
Sex, %Female 88.5 87.5 90 
Race, %Caucasians 100 100 100 
Marital Status, %Married 73.1 75 70 
EDSS, mdn (IQR) 4.0 (2.5) 3.75 (2.75) 4.25 (2.13) 
MS Type, RRMS/SPMS/BGMS 23/2/1 14/1/1 9/1/0 
Disease duration, mean(SD) 21.1 (10.7) 21.9 (10.7) 19.9 (11.2) 
Note. SSE: Square-stepping exercise; SD: Standard deviation; EDSS: Expanded Disability Status Scale; Mdn: Median; 
IQR: (Interquartile range); MS: Multiple sclerosis; RRMS: Relapsing-remitting multiple sclerosis; SPMS: Secondary 
progressive multiple sclerosis; BGMS: benign Multiple sclerosis. 
 
3.2. Process feasibility: recruitment and retention 
Details on participant flow through the trial are provided in the CONSORT diagram in Fig. 2. There were 129 
older adults with MS who were directly contacted to participate in the study; 66 via email and 63 via telephone. 
Recruitment via email yielded 23 interested participants, and recruitment via telephone yielded 40 interested 
participants. Based on these two methods, recruitment rate was 49% (n = 63). We further recruited through MS-
related events, the laboratory website, and local newspapers as additional approaches for recruitment. These 
methods yielded 11 interested participants. Across all recruitment methods, there were 74 interested 
participants in total. Thirty-six potential participants were excluded during telephone screening. Twenty-three 
persons did not meet the inclusion criteria, with 19 being too active (engagement in structured activity for >2 
times per week) and 4 potential participants not meeting age requirements (i.e., younger than 60 years of age)). 
Thirteen potential participants declined to participate during the screening process. Thirty-eight (51%) of the 
interested participants were eligible to participate and were sent a medical release form to be signed by a 
personal physician. Eight medical release forms were not returned and participants were excluded. Thirty 
participants were enrolled and scheduled for the baseline laboratory visit. Four out of 30 dropped out before 
baseline testing. This yielded a final sample of 26 people with MS who were randomized and enrolled into the 
intervention (n = 16) or control condition (n = 10); resulting in nearly 87% retention rate. Twenty-five out of 26 
participants completed the study and post-intervention assessments (96% completion rate). Regarding attrition, 
one participant randomized into the intervention condition did not complete the study. This participant dropped 
out of the study at week 6 (i.e., due to hospitalization followed by death unrelated to the study). Data from this 
participant were not included in our analysis of intervention outcomes. 
 
Fig. 2. CONSORT diagram. Note: In addition there were *27 invalid emails and **11 invalid phone numbers. 
 
3.3. Resources feasibility; communication and monetary requirements 
The phone calls conducted for recruitment purposes (i.e., study presentation) took on average <10 min. Phone 
calls for recruitment plus screening ranged between 12 and 15 min. The mean time to receive signed medical 
release forms was 7 days, and 30% of the sample required a follow-up phone call with the personal physician for 
receipt of medical clearance. The majority (n = 14; 93%) of participants in the intervention condition received all 
weekly Skype™ calls. One participant in the intervention group had problems with the computer and the weekly 
interaction was done via regular phone call. Seventy percent of the participants (n = 7) in the control group 
received the weekly interactions through Skype calls. Three participants in the control condition did not feel 
comfortable using a computer and preferred to do the weekly interaction via regular phone calls. 
The total study cost was $13,387.00 USD. This total included costs related to equipment (i.e., SSE customized 
mats and pedometers; $6982.00 USD), materials (i.e., colored photocopies and binders; approximately $155.00 
USD), and participant incentive ($6250.00 USD). The total costs do not include personal costs (i.e., research 
assistants and investigators). 
3.4. Management feasibility: data management and safety reporting during the study 
The study protocol was submitted to the university IRB on November 29th, 2015 and received approval on 
January 11, 2016. This represented 43 days from initial submission through approval. 
The time necessary to complete the study totaled 349 h (h). This time was distributed across discussions and 
meetings between investigators and staff (48 h), recruitment (database creation, email preparation, journal and 
website advertisement creation, participation in MS-related event; 35 h), recruitment phone calls (40 h); 
material preparation (36 h), data entry and checking (41 h), weekly Skype™ calls (33h) and visits with the 
exercise trainer (112h). Of note, three participants in the intervention group only made it to the first visit with 
the exercise trainer due to the distance from their residence to the laboratory (3 to 3.5 h) and the lack of 
someone to drive them. For these participants, new step patterns were sent by email and participants were 
asked to print a hardcopy to be included in their binder. A research staff was responsible to follow up with 
participants through phone/video call and proceed as close as possible to a normal laboratory visit with the 
exercise trainer (please refer to item 2.2.1 intervention condition). Nevertheless, the 112 h mentioned above 
include the hours of these three participants. An additional 4 h were necessary to retrieve the mats from three 
participants who were unable or forgot to return the mat in the post-assessment session. 
3.5. Scientific; assesses the safety, burden and treatment effect of the study 
3.5.1. Safety 
Two participants in the intervention condition reported adverse events that were unrelated to the study during 
the 12-week intervention period. One person reported a fall (i.e., slipped in the wet garage) and another person 
was hospitalized during the study due to a generalized infection and passed away. One person in the control 
condition reported a discomfort during one of the stretch exercises (i.e., neck stretching) and the specific 
exercise was removed from participant's exercises by the exercise trainer. 
3.5.2. Burden 
The mean time to complete baseline assessment for all participants was 115 min (SD = 17 min) and the mean 
time to complete follow-up assessments for all participants was 89 min (SD = 11 min). The average time for the 
weekly Skype™ calls per participant was 7 min (± 3 min). The average time for the biweekly meeting with the 
exercise trainer per participant was 45 min (± 6 min). 
3.5.3. Compliance 
Four (27%) participants in the intervention condition asked to reschedule the weekly Skype™ calls, but the 
rescheduled calls were within 2 days from the original scheduled date. Seven (47%) participants in the 
intervention condition missed at least one of the biweekly meetings with the exercise trainer (range: 1–3 
meetings). Compliance in the intervention group was further verified through the SSE home practice (i.e., 
average steps per week of session) and through the logbook where information on data and time of practice 
were available. Fig. 3 displays the average steps per week performed during the SSE sessions. Paired samples t-
tests indicated a statistically significant difference on the average number of steps between weeks 1 and 6 
[t(14) = −15.670; P < 0.001] and between weeks 6 and 12 [t(14) = −11.293; P < 0.001]. The average difference in 
steps per week from week 1 to 12 was approximately 8073 steps. Such difference was also found to be 
statistically significant [t(14) = −18.203; P < .001]. 
 
Fig. 3. Average number of steps accumulated per week of square-stepping exercise home practice. 
 
Regarding the control group, one participant (10%) could not be reached for the first scheduled weekly skype 
call due to traveling. Three (30%) participants in the control group missed one biweekly face-to-face meeting 
each with the exercise trainer. Compliance in the control group was further verified through a date and time 
sheet form that was provided to the participants and checked during the biweekly laboratory visits. 
3.5.4. Scientific metrics of treatment outcomes 
Table 4 presents the effect sizes (ηp2) associated with the time by condition interaction for all of the outcome 
variables included in the study. Regarding physical functioning outcomes, there were no statistically significant 
time by group interactions on T25FW (F = .398, P = .534, ηp2 = .017), TUG (F = .306, P = .586, ηp2 = .014), 6 MW 
(F = .001, P = .983, ηp2 = .001), or SPPB (F = .1.347, P = .258, ηp2 = .055). The lack of significance is likely due to 
the small sample size and associated impact on statistical power for a feasibility study. However, effect sizes as 
Cohen's d demonstrate a small-to-moderate improvement for these outcomes in the SSE condition, with the 
largest effect size for the T25FW (d = −.34) and SPPB (d = .30). Similar results were observed for cognitive 
functioning outcomes. There was no statistically significant time by group interactions on SDMT 
(F = .163, P = .691, ηp2 = .007), CVLT (F = .764, P = .391, ηp2 = .032) or BVMT (F = 2.417, P = .134, ηp2 = .095). 
However, effect sizes highlight the small-to-moderate improvements in the SSE condition, with the largest effect 
sizes for the CVLT (d = .40) and BVMT (d = .34). 
Table 4. Outcomes at baseline and follow-up in the intervention (n = 15) and control (n = 10) groups. 
Outcome 
assessment 
Baseline  Post-
intervention 
 Intervention 
Effect (d) 
Control 
Effect 
(d) 
ηp2 F-
value 
 
Intervention 
Mean (SD) 
Control 
Mean 
(SD) 
Intervention 
Mean (SD) 
Control 
Mean 
(SD) 
    
T25FW, sec 6.9 (3.1) 8.8 (3.7) 6.0 (1.6) 8.5 (4.1) −0.34 −0.07 .017 .398 
TUG, sec 10.4 (3.5) 15.1 
(8.0) 
9.7 (2.7) 14.0 (7.3) −0.22 −0.14 .014 .306 
6 MW, ft. 1303.4 
(362.3) 
969.5 
(423.5) 
1392.6 
(415.4) 
1050.8 
(514.5) 
0.23 0.17 .001 .001 
SPPB, pts 8.8 (2.6) 7.2 (3.3) 9.5 (2.1) 7.1 (4.0) 0.30 −0.03 .055 1.347 
SDMT, pts 52.8 (10.7) 42.1 
(15.8) 
53.3 (10.9) 42.0 
(17.1) 
0.05 −0.01 .007 .163 
CVLT, pts 53.6 (10.5) 53.1 
(13.9) 
58.1 (12.3) 54.9 
(14.9) 
0.40 0.12 .032 .764 
BVMT, pts 23.9 (4.8) 22.5 
(6.2) 
25.6 (5.1) 20.3 (4.6) 0.34 −0.40 .095 2.417 
Note: ηp2: partial eta-squared. T25FW: Timed 25-ft Walk Test; TUG: Timed Up and Go Test; 6 MW: 6-min Walk Test, 
SPPB: Short Physical Performance Battery; SDMT: Symbol Digits Modality Test; CVLT: California Verbal Learning Test; 
BVMT: Brief Visual Memory Test. 
4. Discussion 
This manuscript reports results of process, resource, management and scientific feasibility of a home-based, SSE 
program in older adults with MS. The SSE was chosen as the intervention because of its great potential to 
improve common impairments of older adults with MS (e.g., balance, walking, and cognition). The SSE program 
was developed by a group of Japanese researchers with the main goal to prevent falls, improve lower limb 
physical functioning, and enhance aspects of cognition such as memory [18,34]. However, this intervention has 
not been tested for its feasibility in older adults with MS. This exercise method has been effective in improving 
physical functioning in older adults of the general [35,36]. The SSE is a low-cost, indoor or outdoor exercise 
method that is easy to perform. This is mostly due to the fact that the movements/step patterns performed by 
individuals over the SSE mat mimics walking movements. The potential benefits for improving clinical outcomes 
among older adults with MS, similar to those reported in the general population, motivated our adoption the 
SSE program. However, this intervention had not previously been tested for its feasibility in older adults with 
MS. The outcome of process feasibility focused on recruitment and retention rates. The two main approaches 
adopted for recruitment in this study (i.e., email and phone calls), without taking into consideration newspaper 
advertisements and MS-related events, resulted in an overall recruitment rate of 49%. This is comparable with 
the 52% recently observed by researchers in a different home-based study in younger and middle-aged adults 
with MS [37] and higher than previous studies with similar characteristics [[38], [39], [40]] that reported rates 
ranging between 11 and 34%. Our strong recruitment rate indicates that similar processes would be applicable 
in a subsequent phase II trial. Our study further had 87% retention rate (i.e., older adults enrolled and 
randomized into one of the two arms of the study). This number is comparable with previous studies [38,41] and 
demonstrates overall positive study acceptability. 
Regarding metrics of resource feasibility (i.e., communication and monetary requirements), our study provided 
important information for designing a future phase II trial. Regarding communication, our study demonstrated 
that overall Skype™ calls were well accepted by the participants. However, we faced the challenge of some 
participants not being comfortable using computers with Skype™. In those cases, a video call connection could 
not be established and those participants received weekly contact through regular phone calls. This should be 
anticipated in future trials so precautions can be taken to help avoid potential delays in the communication with 
participants. A potential solution would be offering multiple means of communication to participants at the 
beginning of the study. We did not experience any technical issues in terms of Internet connectivity during the 
Skype™ calls or other logistical problems, such as participants not having a computer/tablet/smartphone to 
communicate with the research team. One participant in the control group required an instructional sheet with 
instruction on how to download and use Skype™ and this should be included in future trials. Regarding our 
communication with physicians to obtain the signed medical release, it may be important to plan for extra time 
and/or develop a different approach to accelerate this part of the process. We recruited older adults with MS for 
the current study, and this necessitated medical approval for undertaking the exercise program. Our approach 
was to fax the medical approval form to the physician's office. Members of the research team had to call the 
physician's office for approximately one third of the sample to remind them to complete and sign the form. A 
potential solution to minimize this issue would be asking the participant to bring a hardcopy of the medical 
approval form to the physician's appointment. However, it is important to note that this may necessitate cost to 
the participant to ensure timely enrollment. Gathering information on the costs related to the study was crucial 
to better inform future grant proposals for large-scale research efforts. Our study was accomplished with slightly 
over $13,000 and the majority of this cost was related to the manufacturing of the mats (~$7000) and 
participant's payment (~$6000). The costs related to the mat can be significantly reduced by opting for a 
different material. Our mats used an industrial material which may not be necessary for the purposes of the 
mat. The majority of participants might require travel for the laboratory visits, so this was taken into 
consideration when offering the large incentive. A multi-site study could be a potential way to reduce 
participant's payment in future large-scale trials; but this would come with its own set of challenges and quality 
control that will need to be addressed before hand. The $250 USD paid to participants as an incentive can 
arguably be seen as a potential bias for participation in this study. However, we believe that this amount was 
necessary when considering the costs of transportation. We further do recognize that the cost may limit 
translation into clinical practice, and further research is necessary for examining the SSE intervention under 
conditions amenable for translation into a clinical setting. 
We gathered and provided data on the management requirements of the study. This feasibility trial was 
conducted with the assistance of eight persons, including the PI, Co-PI, two consultants, two graduate students, 
and two undergraduate students, with the majority of the work performed by the PI and two graduate students. 
Twenty-five out of the 26 enrolled and randomized (96%) completed the study, with one participant in the 
intervention condition not completing the follow up assessment. This rate is higher than rates observed in 
previous trials [42]. This is also higher than the normally high dropout rates observed clinical trials in diseased 
populations [43]. Completing and bringing the logbook with the required information during the biweekly 
meetings with the trainer revealed to be a challenge for some participants. In few occasions, the expected 
information was retrieved by phone or by email. This does not seem to be unique to our study as previous work 
reported the needed to follow up with participants to retrieve information [37]; however, strategies should be 
implemented to minimize the potential loss of information. For example, the development of a website linked to 
the program where participants would be able to upload the necessary information. The assessments adopted 
in the study were performed in the laboratory and data were collected by a member of the research team. To 
this end, missing data in this study were related to participants not been able to complete one or more of the 
assessments. 
Participants in the intervention group did not report health problems or adverse events (e.g. relapses) 
associated with the SSE practice. This indicates that home-based SSE is safe to be practiced by older adults with 
MS. This finding is similar to those observed in previous exercise interventions conducted in younger and 
middle-aged adults with MS in terms of safety. A previous systematic review that examined the safety of 
exercise training in persons with MS observed a relapse rate as small as of 4.6% and 6.3% for the exercise and 
control group, respectively [44]. Further, the rates of adverse events were 2% and 1.2% for exercise and control, 
respectively [44]. Overall compliance with the intervention was reasonable, as less than half of participants 
missed a meeting with the exercise trainer. Although important, the meetings with the trainer were a small part 
of the program as the majority of it was performed in the participants' own home without supervision. 
Compliance, measured through steps per session with the use of a pedometer, demonstrated that participants 
complied with the study protocol and the majority of participants were reaching on average 10,000 steps per 
week at the 10th week of the program (Fig. 3). By week 10th week of the program, participants were practicing 
SSE five times per week with a duration of 25–30 min per session. This equates to 2000 steps per session of SSE 
practice by the 10th week of the program. Although this was not our goal/outcome, the 2000 steps accumulated 
during the SSE session could be a significant contributor in helping this population to achieve the recommended 
10,000 steps per day promoted by public health agencies. 
We did not observe nor expect statistically significant effects of the home-based SSE on physical and cognitive 
functioning outcomes. We instead focused on effect sizes (Cohen's d) for the interaction effect from the 
ANOVAs on study outcomes. The partial eta-squared values (ηp2) indicated the interaction between time and 
condition accounted for small variability in the physical functioning (i.e., T25FW, TUG, 6MW, SPPB; 0.1 to 5.5%) 
and cognitive functioning performance tests (i.e., SDMT, CVLT, BVMT; 0.7 to 9.5%). We further focused on 
Cohen's d effect sizes and these indicated a small-to-moderate effect. The largest effects we observed for 
physical and cognitive functions were for T25FW, SPPB, CVLT and BVMT, respectively. This is somewhat 
expected considering that the intervention targeted multiple factors involved in the SPPB (e.g., walking and 
balance) as well as learning and memorizing visuomotor tasks that would translate into changes in the BVMT. 
Overall, the magnitude of the effect sizes ranged from small-to-moderate for both ambulatory/mobility and 
cognitive variables and provides preliminary evidence that participation in the intervention may improve 
cognition and physical function performance in older adults with MS. Similar findings have been observed in 
older adults for the general population [45]. We further note that the next stage of research may focus on SPPB 
and BVMT as primary outcomes of a phase II trial that focuses on the efficacy of the home-based SSE for 
improving physical and cognitive function in older adults with MS. 
Participant satisfaction with the programs deserves a brief discussion, although such information was not 
collected systematically. Based on informal conversations with participants enrolled in the SEE program during 
the biweekly visits in the laboratory, participants reported a positive perception of the program. This was based 
on the easy to perform type of exercise, the fact the SSE program was a fun way to increase physical activity that 
focused on MS-related symptoms, and the fact that the hybrid approach provided participants with a flexibility 
in terms of time of the day they could perform the exercise at home. However, some participants reported that 
as they moved forward with the program in terms of frequency and duration (i.e., 4–5 times per week and 25–
30 min per day) the exercise became too repetitive and “boring”. Based on this, potential changes would include 
a fixed frequency (e.g., 3 times per week) and program progression only in terms of duration (i.e., time per 
session) and difficulty of step pattern (i.e., beginner, intermediate, and advanced). Similarly, a positive 
perception regarding the program was also reported by participants in the stretching and minimal muscle 
strengthening control group. Some participants reported that the stretching exercises improved walking and 
reduce stiffness. Participants further mentioned that the stretching program focused on the whole body was a 
positive point. Despite no negative comments, a potential change for a future trial would be to provide 
participants with a yoga mat and a log book for more similarities to the SSE condition. 
5. Conclusion 
This home-based, SSE program for older adults with MS (i.e., 60 years and over) was safe and feasible. The 
program showed great acceptability and no program-related adverse events or MS-related symptoms 
exacerbation was observed. Overall, results from this feasibility study suggest that the SSE-MS intervention can 
be moved toward a phase II trial of its efficacy for improving physical and cognitive functions [46]. Researchers 
might further consider a similar feasibility study design when developing intervention programs for persons with 
MS in this stage of life (i.e., older adulthood). 
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